A molecule called MEG3 slowed brain tumor cells in lab and mouse tests
Original title: LncRNA MEG3 inhibits glioma progression by inducing pyroptosis through the miR-223-3p/FOXO1/PARP1 axis.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab cells and in mice, not in people.
The short version
Adding back a molecule that is low in glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary made the tumor cells die in lab dishes and slowed tumors in mice.
What was studied. Researchers measured MEG3 and three related molecules in glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary tissue and in tumor cells grown in the lab. They then raised MEG3 levels in the cells, and grew glioma tumors under the skin of mice to watch what happened.
What they found. glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary tissue and glioma cells had much less MEG3 than normal tissue. When the team added MEG3 back, the tumor cells grew, moved, and spread less. The cells died in a kind of cell death called pyroptosis. In mice, more MEG3 slowed tumor growth.
What this means, and what it doesn't
What it could mean: This gives scientists a possible new target to aim at in glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary. It helps explain how these tumors keep growing. It does not change any treatment a patient can get right now.
What it doesn't mean: This is early lab and animal work. The tests were done on cells in dishes and on tumors in mice, not in people. No one knows yet if this would be safe or helpful for a patient. There is no drug or treatment from this work. It is not a promise of a cure, and it could be many years before it means anything for everyday care.
Source: PubMed, July 15, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.